These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7305149)

  • 41. Treatment with haematin in acute hepatic porphyria.
    McColl KE; Moore MR; Thompson GG; Goldberg A
    Q J Med; 1981; 50(198):161-74. PubMed ID: 7302116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hematin administration to an adult with lead intoxication.
    Lamon JM; Frykholm BC; Tschudy DP
    Blood; 1979 May; 53(5):1007-11. PubMed ID: 435635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hematin therapy in late onset congenital erythropoietic porphyria.
    Rank JM; Straka JG; Weimer MK; Bossenmaier I; Taddeini BL; Bloomer JR
    Br J Haematol; 1990 Aug; 75(4):617-8. PubMed ID: 2207013
    [No Abstract]   [Full Text] [Related]  

  • 44. Acute intermittent porphyria.
    Peters HA; Levine R; Cripps D
    Neurology; 1998 Jun; 50(6):1932-3. PubMed ID: 9633780
    [No Abstract]   [Full Text] [Related]  

  • 45. The interaction of the factor VIII/von Willebrand factor complex with hematin.
    Green D; Furby FH; Berndt MC
    Thromb Haemost; 1986 Dec; 56(3):277-82. PubMed ID: 3105105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of factor XII-dependent pathways in human plasma by hematin and protoporphyrin.
    Becker CG; Wagner M; Kaplan AP; Silverberg M; Grady RW; Liem H; Muller-Eberhard U
    J Clin Invest; 1985 Aug; 76(2):413-9. PubMed ID: 4031058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin.
    Bonkowsky HL; Tschudy DP; Collins A; Doherty J; Bossenmaier I; Cardinal R; Watson CJ
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2725-9. PubMed ID: 5288250
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of hematin on endothelial cells and endothelial cell-platelet interactions.
    Neely SM; Gardner DV; Green D; Ts'ao CH
    Am J Pathol; 1984 Jun; 115(3):390-6. PubMed ID: 6375390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physicochemical properties, pharmacokinetics, and pharmacodynamics of intravenous hematin: a literature review.
    Siegert SW; Holt RJ
    Adv Ther; 2008 Sep; 25(9):842-57. PubMed ID: 18777015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Efficacy and tolerability of a new hematin in the treatment of an acute attack of porphyria].
    Fontaine B; Bakchine S; Derouesne C; Nordmann Y; Laplane D
    Presse Med; 1987 Feb; 16(4):177. PubMed ID: 2950457
    [No Abstract]   [Full Text] [Related]  

  • 51. Hemodialysis: a therapeutic option for severe attacks of acute intermittent porphyria in developing countries.
    Prabahar MR; Manorajan R; Sathiyakumar D; Soundararajan P; Jayakumar M
    Hemodial Int; 2008 Jan; 12(1):34-8. PubMed ID: 18271838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hematin: effects on hemostasis.
    Green D; Ts'ao CH
    J Lab Clin Med; 1990 Feb; 115(2):144-7. PubMed ID: 2405084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Acute intermittent porphyria].
    Catania A; Caimi G
    Minerva Med; 1983 Nov; 74(43):2605-9. PubMed ID: 6657112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [What is safe in the therapy of porphyrias?].
    Pierach CA
    Internist (Berl); 1981 Dec; 22(12):726-32. PubMed ID: 7033162
    [No Abstract]   [Full Text] [Related]  

  • 55. Open-label study of hemin for acute porphyria: clinical practice implications.
    Anderson KE; Collins S
    Am J Med; 2006 Sep; 119(9):801.e19-24. PubMed ID: 16945618
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The acute attack of porphyria.
    Disler PB; Eales L
    S Afr Med J; 1982 Jan; 61(3):82-4. PubMed ID: 6120576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.
    Bonkowsky HL; Sinclair PR; Emery S; Sinclair JF
    Neurology; 1980 Jun; 30(6):588-92. PubMed ID: 6770287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatic protoporphyrin production in human protoporphyria. Effects of intravenous hematin and analysis of erythrocyte protoporphyrin distribution.
    Lamon JM; Poh-Fitzpatrick MB; Lamola AA
    Gastroenterology; 1980 Jul; 79(1):115-25. PubMed ID: 7380207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Acute intermittent porphyria: Long-term follow up of 35 patients].
    Herrero C; Badenas C; Aguilera P; To-Figueras J
    Med Clin (Barc); 2015 Oct; 145(8):332-7. PubMed ID: 25194977
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Repression by hematin of porphyrin biosynthesis in erythrocyte precursors in congenital erythropoietic porphyria.
    Watson CJ; Bossenmaier I; Cardinal R; Petryka ZJ
    Proc Natl Acad Sci U S A; 1974 Feb; 71(2):278-82. PubMed ID: 4521800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.